Rodent behavioral phenotyping and in vivo screening of psychoactive compounds are traditionally time-consuming and labor-intensive processes. Manual observation and analysis can introduce bias and limit the throughput of drug discovery efforts.

Blackbox Bio offers an automated platform for rodent behavioral phenotyping and high-throughput in vivo screening of psychoactive medicinal compounds. The system employs advanced imaging technologies to continuously monitor and record rodent behavior in a controlled environment. Proprietary algorithms then analyze the collected data to extract quantitative behavioral metrics, providing researchers with objective and reproducible results. This automated approach accelerates drug discovery by enabling rapid assessment of compound efficacy in preclinical models, while reducing the need for manual observation and analysis.

Automated video tracking and behavioral analysis

High-throughput screening capabilities for in vivo studies

Quantitative behavioral metrics for objective data analysis

Controlled environment for consistent and reproducible results

The primary audience includes pharmaceutical companies, biotechnology firms, and academic research institutions involved in drug discovery and preclinical research.